ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,783Medicare Part D Prescriptions Filled, Including Refills

Rank: 477 out of 6645

$540K Total Retail Price of All Prescriptions

Rank: 1033 out of 6645

378 Patients Receiving at Least One Drug in Part D
97%Patients 65 Years and Older
96% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

5% of this provider’s 378 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 12,582 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
SIMVASTATIN 684 677 1 1
AMLODIPINE BESYLATE 654 640 2 2
OMEPRAZOLE 538 531 3 6
FUROSEMIDE 456 449 4 11
LEVOTHYROXINE SODIUM 406 401 5 4
ZOLPIDEM TARTRATE 405 405 6 17
ATENOLOL 400 395 7 8
BENAZEPRIL HCL 363 353 8 21
HYDROCHLOROTHIAZIDE 335 329 9 9
KLOR-CON 8 326 319 10 123
METOPROLOL SUCCINATE 292 286 11 24
LOSARTAN POTASSIUM 278 264 12 12
ATORVASTATIN CALCIUM 266 262 13 10
LOVASTATIN 226 222 14 15
METOPROLOL TARTRATE 197 197 15 13
TAMSULOSIN HCL 197 197 15 22
ALLOPURINOL 182 182 17 31
ISOSORBIDE MONONITRATE ER 178 178 18 66
LOSARTAN-HYDROCHLOROTHIAZIDE 173 173 19 62
METFORMIN HCL 160 156 20 7
GLYBURIDE-METFORMIN HCL 157 157 R 21 95
GABAPENTIN 144 143 22 18
WARFARIN SODIUM 134 134 23 16
ALENDRONATE SODIUM 120 120 24 14
ESCITALOPRAM OXALATE 119 115 25 86
ZETIA 113 113 26 87
TRAZODONE HCL 112 112 27 60
ADVAIR DISKUS 109 106 28 45
GLYBURIDE 108 107 R 29 58
NAPROXEN 104 104 30 88
TRIAMCINOLONE ACETONIDE 103 96 31 55
JANUVIA 101 101 32 38
DONEPEZIL HCL 97 97 33 27
DOXAZOSIN MESYLATE 97 97 33 81
MECLIZINE HCL 96 96 35 122
PRAVASTATIN SODIUM 95 95 36 20
DIOVAN HCT 85 85 37 64
DIOVAN 81 81 38 19
PAROXETINE HCL 77 73 39 72
CITALOPRAM HBR 71 71 40 35
NEXIUM 69 65 41 40
SPIRIVA 67 67 42 65
ACTOS 65 65 43 71
AMLODIPINE BESYLATE-BENAZEPRIL 64 49 44 97
CARVEDILOL 64 64 44 25
CIPROFLOXACIN HCL 62 61 46 67
NITROSTAT 62 62 46 193
NIFEDIPINE ER 60 60 48 82
ACIPHEX 60 60 48 167
GLIMEPIRIDE 58 58 50 47
PROAIR HFA 58 54 50 32
FLUTICASONE PROPIONATE 57 57 52 26
LIPITOR 56 56 53 69
LIDODERM 54 54 54 53
ACARBOSE 53 53 55 211
KETOCONAZOLE 52 48 56 196
BENICAR HCT 51 51 57 158
LISINOPRIL 51 48 57 3
LEVOXYL 50 50 59 136
SERTRALINE HCL 50 50 59 43
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.